Average Co-Inventor Count = 4.65
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (78 from 4,770 patents)
2. Vitae Pharmaceuticals, Inc. (58 from 85 patents)
3. Boehringer Ingelheim International Gmbh (10 from 1,535 patents)
4. Merck Sharp + Dohme Corp. (7 from 2,405 patents)
5. Other (1 from 832,680 patents)
6. Mercek & Co., Inc. (1 from 1 patent)
7. Vitae Pharmaceuticals, Inc./boehringer-ingelheim (1 from 1 patent)
147 patents:
1. 12312359 - Inhibitors of the menin-MLL interaction
2. 11739085 - Inhibitors of the menin-MLL interaction
3. 11535614 - Dihydropyrrolopyridine inhibitors of ROR-gamma
4. 11479557 - Inhibitors of the menin-MLL interaction
5. 11008340 - Modulators of ROR-gamma
6. 11001583 - Dihydropyrrolopyridine inhibitors of ROR-gamma
7. 10899758 - Inhibitors of the menin-MLL interaction
8. 10829481 - Benzimidazole derivatives as modulators of ROR-gamma
9. 10829448 - Substituted benzoimidazoles as modulators of ROR-γ
10. 10807980 - Dihydropyrrolopyridine inhibitors of ROR-gamma
11. 10683302 - Inhibitors of the menin-MLL interaction
12. 10654884 - Purine derivatives as CD73 inhibitors for the treatment of cancer
13. 10399976 - Dihydropyrrolopyridine inhibitors of ROR-gamma
14. 10336717 - Inhibitors of beta-secretase
15. 10301261 - Substituted indoles as modulators of ROR-gamma